EP 1204754 A2 20020515 - POLYNUCLEOTIDES EXPRESSED IN ACTIVATED T-LYMPHOCYTES AND PROTEINS ENCODED THEREBY
Title (en)
POLYNUCLEOTIDES EXPRESSED IN ACTIVATED T-LYMPHOCYTES AND PROTEINS ENCODED THEREBY
Title (de)
POLYNUCLEOTIDE EXPRIMIERT IN AKTIVIERTEN T-LYMPHOZYTEN UND DIE DAVON KODIERTEN PROTEINE
Title (fr)
POLYNUCLEOTIDES EXPRIMES DANS LES LYMPHOCYTES T ACTIVES ET PROTEINES CODEES PAR CES POLYNUCLEOTIDES
Publication
Application
Priority
- US 0022699 W 20000818
- US 15010599 P 19990820
- US 56153300 A 20000428
- US 56094800 A 20000428
- US 56010100 A 20000428
- US 56036500 A 20000428
Abstract (en)
[origin: WO0114564A2] Disclosed are four novel human nucleic acid sequences expressed in activated T-lymphocytes. Also provided are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to a polypeptide of the invention, or any derivative, variant, mutant or fragment of the polypeptide, polynucleotide or antibody. The invention further provides therapeutic, diagnostic and research methods for treating and diagnosing disorders related to these novel human T-lymphocyte proteins.
IPC 1-7
C12N 15/52; C12N 15/12; C07K 14/47; C07K 14/715; C12N 9/02; C12Q 1/68; C12N 15/11; C12N 15/62; G01N 33/566; C07K 16/18; A01K 67/027; A61K 38/00; C07K 16/40
IPC 8 full level
G01N 33/50 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 1/16 (2006.01); A61P 1/18 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 17/06 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); C07K 14/47 (2006.01); C07K 14/715 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/02 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61P 1/16 (2017.12); A61P 1/18 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 17/06 (2017.12); A61P 25/00 (2017.12); A61P 25/28 (2017.12); A61P 31/00 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); C07K 14/47 (2013.01); C07K 14/4702 (2013.01); C07K 14/715 (2013.01); C12N 9/0036 (2013.01); A01K 2217/05 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01)
Citation (search report)
See references of WO 0114564A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0114564 A2 20010301; WO 0114564 A3 20011122; AU 6785700 A 20010319; CA 2382123 A1 20010301; EP 1204754 A2 20020515; JP 2003507070 A 20030225
DOCDB simple family (application)
US 0022699 W 20000818; AU 6785700 A 20000818; CA 2382123 A 20000818; EP 00955700 A 20000818; JP 2001518877 A 20000818